Skip to main
SBRA

SBRA Stock Forecast & Price Target

SBRA Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 0%
Buy 38%
Hold 63%
Sell 0%
Strong Sell 0%

Bulls say

Sabra Health Care REIT Inc. has demonstrated continued improvements in occupancy and rent coverage, indicating a strengthening operational performance within its healthcare real estate portfolio. Additionally, the expectation of a recovery in the seniors housing managed portfolio is anticipated to enhance the company's leverage profile, positioning it for future growth opportunities. Furthermore, the increase in the 2025 FFO estimate to $1.54 per share reflects a robust financial outlook, supported by higher investment volumes and favorable demand drivers in the healthcare real estate sector.

Bears say

Sabra Health Care REIT faces significant challenges in predicting individual operator performance, with many operators struggling to meet rent obligations amid inflationary pressures, which could impact revenue stability. The company has a higher leverage compared to several peers and is trading near the peak of its 10-year stock valuation range, indicating potential overvaluation. Additionally, the estimated cost of equity offers limited potential for earnings accretion from acquisitions, suggesting constrained growth prospects in a competitive healthcare REIT sector.

SBRA has been analyzed by 8 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 38% recommend Buy, 63% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sabra Health Care and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sabra Health Care (SBRA) Forecast

Analysts have given SBRA a Hold based on their latest research and market trends.

According to 8 analysts, SBRA has a Hold consensus rating as of Jan 24, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sabra Health Care (SBRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.